Thomas K Equels - 30 Nov 2022 Form 4 Insider Report for AIM ImmunoTech Inc. (AIMI)

Role
CEO & President, Director
Signature
/s/ Thomas K. Equels
Issuer symbol
AIMI
Transactions as of
30 Nov 2022
Net transactions value
$0
Form type
4
Filing time
02 Dec 2022, 15:50:26 UTC
Previous filing
18 Jul 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIM Options Award $0 +300,000 $0.000000 300,000 30 Nov 2022 Common Stock 300,000 $0.4100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued pursuant to employment agreement with Reporting Person.